Home/Filings/4/0001562180-24-002480
4//SEC Filing

WILLIAMS DOUGLAS E 4

Accession 0001562180-24-002480

CIK 0001770121other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:18 PM ET

Size

8.4 KB

Accession

0001562180-24-002480

Insider Transaction Report

Form 4
Period: 2024-03-07
WILLIAMS DOUGLAS E
EVP & President, R&D
Transactions
  • Award

    Restricted Stock Units

    2024-03-07+67,08367,083 total
    Common Stock (67,083 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-03-07+301,875301,875 total
    Exercise: $9.58Exp: 2034-03-06Common Stock (301,875 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
  • [F2]The restricted stock units vest in four equal installments on each of March 7, 2025, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
  • [F3]The option vests and becomes exercisable as to 25% of the underlying shares on March 7, 2025 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001184847

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:18 PM ET
Size
8.4 KB